ReviewSurgical endoscopy2025
Long-term outcome of rendezvous internalization treatment for external pancreatic fistulas associated with disconnected pancreatic duct syndrome: a retrospective study.
Review in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Timing and Location are Keys: ERCP Success and Its Benefit in MPD Injury after Acute Pancreatitis.Current medical science · 2026Article
- Management of walled-off pancreatic necrosis (WON) beyond the conventional step-up strategy: a retrospective cohort study.Surgical endoscopy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWalled-off pancreatic necrosis resulting from severe necrotizing pancreatitis often leads to complications, including disconnected pancreatic duct syndrome (DPDS) and the subsequent development of external pancreatic fistulas (EPFs). This study aimed to evaluate the long-term outcome of rendezvous internalization treatment for EPF associated with DPDS.
methodsA retrospective review of 40 patients with EPFs secondary to DPDS who underwent rendezvous treatment between October 2008 and October 2023 was conducted. Three techniques were utilized: outside-in (n = 18), inside-out (n = 19), and pancreatic duct bridging (n = 3). Primary outcomes included the rate of surgery post-treatment, while secondary outcomes encompassed recurrence of peripancreatic fluid collection (PFC) or EPF.
resultsThe mean age of patients was 54.6 years, with 67.5% being male. Gallstones (37.5%) and alcohol (25.0%) were the leading etiologies. The median time from pancreatitis onset to the procedure was 216 days. All patients achieved EPF closure, with a median closure time of 20 days. Procedure-related complications included post-procedural acute pancreatitis (12.5%) and minor bleeding (7.5%), with no perforations or mortality. During a median follow-up of 53.5 months, recurrence of EPF occurred in three patients (7.5%), with two requiring surgery (5.0%). Recurrence of PFC (22.5%) and acute pancreatitis (17.5%) were also observed. New-onset diabetes mellitus occurred in 50% of patients.
conclusionRendezvous internalization treatments are highly effective for EPFs associated with DPDS, achieving high closure rates and low recurrence. These findings underscore their potential to reduce surgical necessity. Prospective studies are warranted to optimize strategies for these challenging cases.
Indexed as
Identifiers
40126625What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.